Cargando…

Health-Related Quality of Life and Influencing Factors in Coronary Heart Disease Based on the Scale QLICD-CHD (V2.0): A Cross-Sectional Study

PURPOSE: Coronary heart disease (CHD) is difficult to cure, so more attention should be paid to improving patients’ health-related quality of life (HRQoL). This paper focuses on identifying factors that affect HRQoL. PATIENTS AND METHODS: Overall, 189 in-patients with coronary heart disease were inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Shuying, Xu, Chuanzhi, Wan, Chonghua, Huang, Zhiwen, Huang, Xingping, Chen, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637221/ https://www.ncbi.nlm.nih.gov/pubmed/37954655 http://dx.doi.org/10.2147/IJGM.S430169

Ejemplares similares

Development and validation of a disease-specific quality of life measure QLICD-HY (V2.0) for patients with hypertension
por: Liu, Yuxi, et al.
Publicado: (2023)

Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability theory
por: Wan, Chonghua, et al.
Publicado: (2014)

Development and validation of the psoriasis scale among the system of quality of life instruments for chronic diseases QLICD-PS (V2.0)
por: Liu, Qiongling, et al.
Publicado: (2022)

Development and validation of the pulmonary tuberculosis scale of the system of Quality of Life Instruments for Chronic Diseases (QLICD-PT)
por: Sun, Yanchun, et al.
Publicado: (2018)

Development and validation of the systemic lupus erythematous scale amongst the system of quality of life instruments for chronic diseases QLICD-SLE (V2.0)
por: Liu, Yuxi, et al.
Publicado: (2023)

Short-form development of the specific module of the QLICD-CRF(V2.0) for assessing the quality of life of patients with chronic renal failure
por: Xiao, Zhengqin, et al.
Publicado: (2022)

Development and validation of quality of life instruments for chronic diseases—Chronic gastritis version 2 (QLICD-CG V2.0)
por: Quan, Peng, et al.
Publicado: (2018)

Canonical correlation analysis of factors that influence quality of life among patients with chronic obstructive pulmonary disease based on QLICD-COPD (V2.0)
por: Liu, Yuxi, et al.
Publicado: (2022)

Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods
por: Wu, Xiaoyu, et al.
Publicado: (2023)

Health-related quality of life and influencing factors in drug addicts based on the scale QLICD-DA: a cross-sectional study
por: Ma, Zilin, et al.
Publicado: (2022)

Development and Validation of the Chronic Gastritis Scale Under the System of Quality of Life Instruments for Chronic Diseases QLICD-CG Based on Classical Test Theory and Generalizability Theory
por: Wan, Chonghua, et al.
Publicado: (2022)

The relationship between fetuin-A and coronary atherosclerotic heart disease (CHD) and CHD-related risk factors: A retrospective study
por: Zheng, Jianping, et al.
Publicado: (2021)

Personality Traits Predict Life Satisfaction in Coronary Heart Disease (CHD) Patients
por: Kang, Weixi
Publicado: (2022)

Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
por: Zhou, Xuan, et al.
Publicado: (2023)

Understanding Cognitive Deficits in People with Coronary Heart Disease (CHD)
por: Kang, Weixi, et al.
Publicado: (2023)

Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors
por: Mondesir, Favel L, et al.
Publicado: (2019)

Exploration of the methods of establishing the minimum clinical important difference based on anchor and its application in the quality of life measurement scale QLICP-ES (V2.0) for esophageal cancer
por: Ren, Dandan, et al.
Publicado: (2021)

Development and Validation of the Breast Cancer Scale QLICP-BR V2.0 Based on Classical Test Theory and Generalizability Theory
por: Li, Fei, et al.
Publicado: (2022)

Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis
por: Zhao, Luqian, et al.
Publicado: (2016)

Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
por: Kristoffersen, Agnete E, et al.
Publicado: (2012)

Premature coronary heart disease risk factors & reducing the CHD burden in India
por: Prabhakaran, Dorairaj, et al.
Publicado: (2011)

The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects
por: Shabana, et al.
Publicado: (2020)

Individuals at Risk of Coronary Heart Disease (CHD), its Prevention and Management by an Indigenous Compound
por: Dubey, G.P., et al.
Publicado: (2000)

CT coronary angiography vs. invasive coronary angiography in CHD
por: Gorenoi, Vitali, et al.
Publicado: (2012)

Establishing Minimal Clinically Important Differences for the Quality of Life Instrument in Patients With Breast Cancer QLICP-BR (V2.0) Based on Anchor-Based and Distribution-Based Methods
por: Li, Fei, et al.
Publicado: (2022)

CHD@ZJU: a knowledgebase providing network-based research platform on coronary heart disease
por: Wu, Leihong, et al.
Publicado: (2013)

Comparison of anger management, anxiety and perceived stress in patients with cancer and Coronary Heart Disease (CHD)
por: Aghaei, M, et al.
Publicado: (2015)

Logit model in prospective coronary heart disease (CHD) risk factors prediction in Saudi population
por: Babiker, Sawsan, et al.
Publicado: (2021)

Using linked records to improve National estimates of hospital admissions for coronary heart disease (CHD)
por: Lopez, Derrick, et al.
Publicado: (2017)

The Yale Food Addiction Scale 2.0 and the modified Yale Food Addiction Scale 2.0 in Taiwan: Factor structure and concurrent validity
por: Chen, I-Hua, et al.
Publicado: (2022)

Yale Food Addiction Scale 2.0 (YFAS 2.0) and modified YFAS 2.0 (mYFAS 2.0): Rasch analysis and differential item functioning
por: Saffari, Mohsen, et al.
Publicado: (2022)

Development and testing of innovative patient resources for the management of coronary heart disease (CHD): a descriptive study
por: Redfern, Julie, et al.
Publicado: (2006)

Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium
por: Patel, Riyaz S., et al.
Publicado: (2019)

Prevalence and Related Risk Factors Associated with Coronary Heart Disease (CHD) Among Middle-Aged and Elderly Patients with Vision Impairment (VI)
por: Qin, Shengmei, et al.
Publicado: (2021)

Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD
por: Polonskaya, Yana V., et al.
Publicado: (2021)

Influence of Comprehensive Life Style Intervention in Patients of CHD
por: Dehghani, Ali, et al.
Publicado: (2015)

Genome-Wide Association Analysis of Incident Coronary Heart Disease (CHD) in African Americans: A Short Report
por: Barbalic, Maja, et al.
Publicado: (2011)

PERCEPTIONS OF PRIMARY HEALTH CARE (PHC) DOCTORS ON THE PREVENTION OF CORONARY HEART DISEASE (CHD) IN RIYADH, SAUDI ARABIA
por: Al-Shehri, Ali M.
Publicado: (2009)

Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD)
por: Shimizu, Rumiko, et al.
Publicado: (2016)

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)
por: Akkaif, Mohammed Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n3kotf1o7od0uspcnpolr22b4b